Cas 890839-32-4,4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid

890839-32-4

Post Buying Request

Basic information

Product Name: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid
Synonyms: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid
CAS NO:890839-32-4
Molecular Formula:
Molecular Weight: 384.083
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid(CAS DataBase Reference)
NIST Chemistry Reference: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid(890839-32-4)
EPA Substance Registry System: 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-bis(trifluoromethyl)benzoic acid(890839-32-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 890839-32-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

890839-32-4 Suppliers

Recommended suppliers

890839-32-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 890839-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,8,3 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 890839-32:
(8*8)+(7*9)+(6*0)+(5*8)+(4*3)+(3*9)+(2*3)+(1*2)=214
214 % 10 = 4
So 890839-32-4 is a valid CAS Registry Number.

890839-32-4Upstream product

890839-32-4Downstream Products

890839-32-4Relevant academic research and scientific papers

1H-PYRROLO[2,3-B]PYRIDINES

-

Page/Page column 32, (2008/06/13)

Derivatives of pyrrolo[2,3-b]pyridine which are useful as SGK-1 kinase inhibitors are described herein. The invention described herein also describes pharmaceutical compositions containing derivatives of pyrrolo[2,3-b]pyridine and methods of using pyrrolo[2,3-b]pyridine derivatives and pharmaceutical compositions thereof in the treatment of diseases mediated by SGK-1.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 890839-32-4